The global hematology analyzers and reagents market accounted for a value of 16.0 billion in 2019 and is projected to register growth at a CAGR of 17.1% during forecast period.
COVID-19 has impacted the hematology analyzers and reagents market. The transmission of corona virus is increasing around the world. The manufacturing units have to halt its production due to lockdown and the supply chain got disrupted due to travel restriction. The number of visits in hospitals for routine checkup or for other issues is decreasing and the pre-planned appointment are delayed or postponed. Thus, the hematology analyzers and reagents market will foresee growth after resuming of normalcy.
For more details, visit: Global Hematology Analyzers and Reagents Market By Product & Services (Hematology, Hemostasis, Others), By Application (Wound Anemias, Blood Cancers, Others), By End-Users, By Region, Forecast & Opportunities to 2026
The number blood donations is growing and incidence of blood disorders is immensely increasing and this requires hematology analyzers and reagents in order to efficiently treat the blood disorders. This increases the adoption of hematology analyzers and reagents and drives growth in this market.
On the basis of product & services, the hematology analyzers and reagents market is segmented into hematology, hemostasis and immunohematology. The hematology segment accounted for largest market share in 2019. The adoption of POC testing hematology analyzers is increasing in emerging economies. The technologically advanced hematology products are being launching. The preference towards automation is increasing in the healthcare sector in the world. Hematology providers provide wide range of services which increases demand and adoption of hematology segment and drives growth in this segment during forecast period.
On the basis of end-user, the hematology analyzers and reagents market is segmented into hospital laboratories, government reference laboratories, commercial service providers and research & academic institutes. The commercial service providers segment accounted for largest market share in 2019 and it is estimated to dominate the market during forecast period. The incidence of anemia and leukemia are increasing in the world and the healthcare is shifting from manual testing to automated testing. The commercial service providers segment provides efficient management and affordable cost. Thus, drives growth in commercial service providers segment during forecast period.
North America region is estimated to account for largest market share in 2019 and it is estimated to dominate the market during forecast period. The incidence of blood disorders and patients suffering is increasing immensely in this region. The demand for blood transfusions is increasing in this region and this increases demand and adoption of hematology analyzers and reagents in this region and drives growth in North America region during forecast period.
The key market players in hematology analyzers and reagents are Roche, Abbott Laboratories, Danaher Corporation, Diatron, Drew Scientific Group, Siemens Health Thineers Group, Sysmex Corporation, Bio-Rad Laboratories, Horiba, Nihon Kohden, EKF Diagnostics, Boule Diagnostics AB, Mindray, Biosystems S.A., Ortho Clinical Diagnostics, Drucker Diagnostics and Vital Diagnostics.
- What are the expected industry trends over the next three to five years?
- Which of the hematology analyzers and reagents application is likely to lead by 2025?
- Which of the end-user segments is expected to have the maximum potential to during the forecast period?
- Which region is going to have the highest smart meters market share by 2025?
- What are different organic and inorganic strategies implemented by companies to gain increased market share?